The following table presents shares used in the calculation of basic and diluted net income per share:


	Three Months Ended				Nine Months Ended
	June 30,				June 30,
	2025		2024		2025		2024
Weighted average common shares outstanding used in calculating basic net income per share		21,515,092		22,268,758		22,249,076		22,254,619
Effect of dilutive options and non-vested restricted stock awards		—		780,339		—		697,615
Weighted average common and common equivalent shares used in calculating diluted net income per share		21,515,092		23,049,097		22,249,076		22,952,234

There were approximately 1.9 million and 0.01 million weighted average shares of options outstanding and non-vested restricted stock outstanding, for the three months ended June 30, 2025 and 2024, respectively, that were not included in the computation of diluted net income per share because their effect would be anti-dilutive. For the nine months ended June 30, 2025 and 2024, there were approximately 1.8 million and 0.01 million weighted average shares of options outstanding and non-vested restricted stock outstanding, respectively, that were not included in the computation of diluted net income per share because the options’ exercise prices or non-vested restricted stock prices were greater than the average market price of our common stock, and therefore, their effect would be anti-dilutive.